|
PAXIP1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.696800E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.662100E-02 |
| Normal-vs-Stage2 |
7.509200E-01 |
| Normal-vs-Stage3 |
8.665400E-01 |
| Normal-vs-Stage4 |
8.731200E-01 |
| Stage1-vs-Stage2 |
3.432200E-01 |
| Stage1-vs-Stage3 |
5.882000E-02 |
| Stage1-vs-Stage4 |
1.654230E-01 |
| Stage2-vs-Stage3 |
6.748200E-01 |
| Stage2-vs-Stage4 |
8.540400E-01 |
| Stage3-vs-Stage4 |
7.736600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.418600E-01 |
| Normal-vs-AfricanAmerican |
3.615800E-01 |
| Normal-vs-Asian |
9.407900E-02 |
| Caucasian-vs-AfricanAmerican |
9.197900E-02 |
| Caucasian-vs-Asian |
5.346400E-02 |
| AfricanAmerican-vs-Asian |
9.861300E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.005800E-01 |
| Normal-vs-Female |
2.067600E-01 |
| Male-vs-Female |
5.696000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.362600E-01 |
| Normal-vs-Age(41-60Yrs) |
2.143400E-01 |
| Normal-vs-Age(61-80Yrs) |
3.845200E-01 |
| Normal-vs-Age(81-100Yrs) |
4.616200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.455200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.393800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.653800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.661000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.630040E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.186000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.119790E-03 |
| Normal-vs-Grade 2 |
5.244000E-02 |
| Normal-vs-Grade 3 |
6.062400E-01 |
| Normal-vs-Grade 4 |
3.126600E-01 |
| Grade 1-vs-Grade 2 |
7.652100E-02 |
| Grade 1-vs-Grade 3 |
2.830000E-02 |
| Grade 1-vs-Grade 4 |
5.401000E-03 |
| Grade 2-vs-Grade 3 |
1.359750E-01 |
| Grade 2-vs-Grade 4 |
9.617300E-03 |
| Grade 3-vs-Grade 4 |
1.527410E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.076250E-03 |
| Normal-vs-ccB subtype |
3.605600E-01 |
| ccA subtype-vs-ccB subtype |
2.02739999999313E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.645600E-01 |
| Normal-vs-N1 |
7.238000E-01 |
| N0-vs-N1 |
8.902400E-01 |
|
|
